Durlobactam

CAS No. 1467829-71-5

Durlobactam( Durlobactam )

Catalog No. M12004 CAS No. 1467829-71-5

Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2043 Get Quote
50MG 4122 Get Quote
100MG 5760 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Durlobactam
  • Note
    Research use only, not for human use.
  • Brief Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • Description
    Durlobactam is a novel beta-lactamase inhibitor for treatment of resistant bacterial infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Durlobactam
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1467829-71-5
  • Formula Weight
    277.251
  • Molecular Formula
    C8H11N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(O)(ON1[C@]2([H])C=C(C)[C@@H](C(N)=O)[N@@](C2)C1=O)=O
  • Chemical Name
    (1R,2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl hydrogen sulfate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Propargylcholine

    Propargylcholine is an alkyne-modified choline analog and inhibits choline catabolism at the level of Dgc enzyme-catalyzed dimethylglycine demethylation in Pseudomonas aeruginosa.

  • 3-Hydroxy-C4-HSL

    3-Hydroxy-C4-HSL (N-3-hydroxybutyryl-L-Homoserine lactone) is an N-acyl homoserine lactone obtained from pathogenic Vibrio vulnificus in fish and is a bacterial group sensing (QS) inducer that modulates bacterial signaling and can be used in the study of bacterial infections.

  • CB-618

    CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.